AKR1B10 Anticorps
(Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))
Choisissez l’un des 44 anticorps AKR1B10 de notre liste de produits basés sur 12 publications et 42 images de validation.
Découvrez des anticorps AKR1B10 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de AKR1B10 dans plusieurs espèces, y compris Human, Mouse, Rat, Horse, Zebrafish (Danio rerio), Cow, Dog, Guinea Pig, Rabbit, Saccharomyces cerevisiae, et prend en charge diverses applications de recherche telles que WB, IHC, IF, ELISA, ICC.
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants AKR1B10, issus de différents hôtes tels que Rabbit, Mouse, Goat. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de AKR1B10 sont AKR1B10, Akr1b10, AKR1B10L2, LOC100585902, LOC100723118, LOC101107697.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| AKR1B10 anticorps (C-Term) (FITC) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| AKR1B10 anticorps (C-Term) (Fluoro488) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| AKR1B10 anticorps (C-Term) (PE) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
|
| AKR1B10 anticorps (C-Term) (Fluoro647) | Humain | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- C-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- IHC (Immunohistochemistry: Application indiquée)
- IF (Immunofluorescence: Application indiquée)
- ICC (Immunocytochemistry: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- C-Term
Dernières publications pour nos AKR1B10 Anticorps
: "Quantification of the host response proteome after herpes simplex virus type 1 infection." dans: Journal of proteome research, Vol. 14, Issue 5, pp. 2121-42, (2015) (PubMed).
: "Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions." dans: Human pathology, Vol. 45, Issue 4, pp. 834-43, (2014) (PubMed).
: "SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." dans: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
: "Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma." dans: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 25, Issue 5, pp. 758-66, (2012) (PubMed).
: "A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals." dans: Scientific reports, Vol. 2, pp. 280, (2012) (PubMed).
: "An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma." dans: The Journal of pathology, Vol. 228, Issue 3, pp. 274-85, (2012) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." dans: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases." dans: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, Issue 6, pp. 810-6, (2011) (PubMed).
: "Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity." dans: Cancer research, Vol. 71, Issue 12, pp. 4161-71, (2011) (PubMed).
: "Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin." dans: The Journal of pharmacology and experimental therapeutics, Vol. 335, Issue 3, pp. 533-45, (2010) (PubMed).
: "Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions." dans: Human pathology, Vol. 45, Issue 4, pp. 834-43, (2014) (PubMed).
: "SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma." dans: Journal of hepatology, Vol. 59, Issue 3, pp. 510-7, (2013) (PubMed).
: "Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma." dans: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 25, Issue 5, pp. 758-66, (2012) (PubMed).
: "A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals." dans: Scientific reports, Vol. 2, pp. 280, (2012) (PubMed).
: "An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma." dans: The Journal of pathology, Vol. 228, Issue 3, pp. 274-85, (2012) (PubMed).
: "Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29." dans: Chemico-biological interactions, Vol. 191, Issue 1-3, pp. 239-49, (2011) (PubMed).
: "AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases." dans: Liver international : official journal of the International Association for the Study of the Liver, Vol. 31, Issue 6, pp. 810-6, (2011) (PubMed).
: "Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity." dans: Cancer research, Vol. 71, Issue 12, pp. 4161-71, (2011) (PubMed).
: "Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin." dans: The Journal of pharmacology and experimental therapeutics, Vol. 335, Issue 3, pp. 533-45, (2010) (PubMed).
Pseudonymes pour AKR1B10 Anticorps
aldo-keto reductase family 1 member B10 (AKR1B10) Anticorpsaldo-keto reductase family 1, member B10 (aldose reductase) (Akr1b10) Anticorps
aldo-keto reductase family 1 member B10-like 2 (AKR1B10L2) Anticorps
aldo-keto reductase family 1 member B10 (Akr1b10) Anticorps
aldo-keto reductase family 1 member B10 (LOC100585902) Anticorps
aldo-keto reductase family 1 member B10 (LOC100723118) Anticorps
aldo-keto reductase family 1 member B10 (LOC101107697) Anticorps
2310005E10Rik Anticorps
AKR Anticorps
AKR1B10 Anticorps
Akr1b10 Anticorps
AKR1B11 Anticorps
AKR1B12 Anticorps
Akr1b16 Anticorps
ALDRLn Anticorps
ARL-1 Anticorps
ARL1 Anticorps
HIS Anticorps
HSI Anticorps
Avez-vous cherché autre chose?
- AKR1B1 Anticorps
- AKR1A1 Anticorps
- AKNA Domain Containing 1 Anticorps
- AKNA Anticorps
- AKIRIN2 Anticorps
- AKIP1 Anticorps
- AKAP9 Anticorps
- AKAP8L Anticorps
- AKAP8 Anticorps
- AKAP7 Anticorps
- AKAP6 Anticorps
- AKAP5 Anticorps
- AKAP4 Anticorps
- AKAP3 Anticorps
- AKAP2 Anticorps
- AKAP14 Anticorps
- AKAP13 Anticorps
- AKAP12 Anticorps
- AKAP11 Anticorps
- AKAP10 Anticorps
- AKR1C1 Anticorps
- AKR1C2 Anticorps
- AKR1C3 Anticorps
- AKR1C4 Anticorps
- AKR1D1 Anticorps
- AKR1E2 Anticorps
- AKR7A2 Anticorps
- AKR7A3 Anticorps
- AKT Interacting Protein Anticorps
- AKT2 Anticorps
- AKT3 Anticorps
- ALAD Anticorps
- Alanine Glyoxylate Aminotransferase Anticorps
- Alanyl (Membrane) Aminopeptidase Anticorps
- Alanyl-tRNA Synthetase Anticorps
- ALAS1 Anticorps
- ALAS2 Anticorps
- Albumin Anticorps
- Alcohol Dehydrogenase Anticorps
- Alcohol Dehydrogenase 7 (Class IV), mu Or sigma Polypeptide Anticorps
Vous êtes ici:
